Healthcare / Medical Care FacilitiesNasdaqGM
$16.78
+0.16 (+0.96%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 28% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-17.6M · quality 27.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
4/9
balance/quality
Valuation
100/100
+606.0% upside
5Y CAGR
+62.5%
100/100
Data QA
85/100
SEC 93%
Sin guardar todavía.
Market Cap
$168M
P/E
1.6x
↓EV/EBITDA
0.4x
↓ROE
332.0%
↑Gross Margin
71.8%
↑Debt/Equity
1.47
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
-4.7%
FCF CAGR
—
FCF margin
-6.5%
FCF / Net income
-0.04x
Latest source
SEC-backed
Margin decomposition
Último año: revenue $710.6M · net income $1.06B · FCF $-46.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024SEC | 2023SEC | 2022SEC | 2021SEC | 2019SEC | 2018SEC | 2017SEC | 2016SEC | 2015SEC | 2013SEC | 2012SEC | 2011SEC | 2010SEC | 2009SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | $710.6M | $710.6M | $785.9M | $889.6M | $1.21B | $323.4M | $1.41B | $1.51B | $1.31B | $1.16B | $1.48B | $1.72B | $1.84B | $1.45B | $1.40B | $1.54B |
| Net Income | $1.06B | $1.06B | $-345.7M | $-88.1M | $67.1M | $12.6M | $119.6M | $223.7M | $163.5M | $32.9M | $117.8M | $202.7M | $257.4M | $194.2M | $177.3M | $204.3M |
| EBITDA | $1.22B | $1.22B | $-198.4M | $74.7M | $-235.2M | $275.7M | $342.3M | $441.6M | $324.3M | $259.6M | $357.9M | $478.1M | $529.6M | $560.8M | $370.9M | $449.6M |
| EPS | 7.58 | 7.58 | -4.34 | -1.46 | 0.95 | 0.18 | 1.72 | 3.19 | 2.40 | 0.56 | 2.08 | 3.60 | 4.23 | 2.56 | 2.30 | 2.60 |
| Gross Margin | 71.8% | 71.8% | 67.8% | 59.5% | 60.0% | 56.3% | 55.7% | 57.2% | 53.0% | 49.3% | 54.2% | 58.1% | 59.5% | 54.4% | 52.0% | 54.4% |
| Operating Margin | 6.5% | 6.5% | -30.1% | 2.5% | 16.2% | 14.7% | 20.4% | 25.7% | 20.5% | 14.4% | 20.2% | 26.5% | 27.8% | 26.9% | 25.5% | 27.7% |
| Net Margin | 148.6% | 148.6% | -44.0% | -9.9% | 5.5% | 3.9% | 8.5% | 14.8% | 12.5% | 2.8% | 8.0% | 11.8% | 14.0% | 13.4% | 12.7% | 13.3% |
| Balance Sheet | ||||||||||||||||
| Debt/Equity | 1.47 | 1.47 | 1.28 | 1.87 | 3.13 | 2.71 | 2.30 | 2.16 | 1.79 | 1.71 | 1.72 | 1.62 | 1.44 | 1.96 | 1.97 | — |
| Current Ratio | 1.19 | 1.19 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||
| Free Cash Flow | $-46.4M | $-46.4M | $-17.6M | $4.2M | $154.8M | $114.5M | $165.2M | $276.5M | $208.5M | $113.5M | — | $282.9M | $287.9M | $272.5M | $253.2M | $224.9M |
| Returns | ||||||||||||||||
| ROE | 332.0% | 332.0% | -31.0% | -11.6% | 14.8% | 2.3% | 17.4% | 27.7% | 16.1% | 2.6% | 8.6% | 13.7% | 15.5% | 28.0% | 24.1% | 23.0% |
| Valuation | ||||||||||||||||
| P/E | 1.57 | 1.57 | — | — | 10.74 | 56.67 | 5.93 | 3.20 | 4.25 | 18.21 | 4.90 | 2.83 | 2.41 | 3.98 | 4.43 | 3.92 |
| EV/EBITDA | 0.39 | 0.39 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 0.53 | 0.53 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||
| Revenue Growth | -9.6% | -9.6% | -11.6% | -26.6% | 274.5% | -77.1% | -6.7% | 15.9% | 12.2% | -21.3% | -14.2% | -6.3% | 26.7% | 3.8% | -8.9% | — |
| EPS Growth | 274.7% | 274.7% | -197.3% | -253.7% | 427.8% | -89.5% | -46.1% | 32.9% | 328.6% | -73.1% | -42.2% | -14.9% | 65.2% | 11.3% | -11.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-41.9%
EPS terminal req.
$1.49
Spread vs growth
316.5%
5Y implied EPS CAGR
-25.0%
EPS terminal req.
$1.80
Spread vs growth
299.6%
10Y implied EPS CAGR
-9.2%
EPS terminal req.
$2.90
Spread vs growth
283.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-37.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-4.34 → 7.58
Residual
-37.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.